Table 2.
Outcome variables of each group in each measurement.
| Variables | TAU | TAU+LMP | TAU+LMP+ICTs |
|---|---|---|---|
| BDI-II, M (SD) | |||
| T0 | 24.13 (5.05) | 25.00 (4.94) | 25.58 (5.29) |
| T1 | 27.45 (9.08) | 18.16 (8.53) | 19.94 (8.08) |
| T2 | 24.00 (12.72) | 18.49 (9.95) | 17.69 (11.79) |
| T1-T0 | 3.29 (7.55) | −6.43 (7.77) | −5.59 (6.74) |
| T2-T0 | −0.12 (12.06) | −5.48 (9.50) | −7.71 (11.52) |
| IPAQ-SF-walking, M (SD) | |||
| T0 | 208.25 (324.92) | 233.25 (261.87) | 177.42 (226.87) |
| T1 | 177.93 (346.64) | 380.56 (371.98) | 367.34 (430.34) |
| T2 | 211.12 (279.09) | 368.43 (338.27) | 373.33 (351.61) |
| T1-T0 | −13.96 (410.85) | 145.34 (250.76) | 205.30 (432.34) |
| T2-T0 | 5.51 (270.41) | 123.56 (251.74) | 189.88 (350.99) |
| IPAQ-SF-sedentarism, M (SD) | |||
| T0 | 256.75 (212.23) | 306.67 (180.20) | 306.77 (160.72) |
| T1 | 280.69 (210.17) | 240.11 (160.67) | 248.57 (150.99) |
| T2 | 302.45 (188.73) | 277.97 (172.68) | 261.67 (184.03) |
| T1-T0 | 13.96 (223.10) | −51.70 (135.25) | −52.04 (149.22) |
| T2-T0 | 49.49 (211.65) | −2.56 (167.48) | −32.62 (189.61) |
| PSQI, M (SD) | |||
| T0 | 11.57 (4.91) | 12.11 (4.34) | 11.29 (4.69) |
| T1 | 12.29 (3.95) | 9.25 (4.12) | 10.65 (4.91) |
| T2 | 10.59 (5.74) | 8.70 (4.20) | 9.85 (5.06) |
| T1-T0 | 0.51 (3.79) | −2.68 (3.77) | −0.73 (3.25) |
| T2-T0 | −1.32 (5.11) | −3.21 (4.36) | −1.52 (5.13) |
| MEDAS, M (SD) | |||
| T0 | 6.41 (1.81) | 6.54 (2.08) | 6.45 (1.70) |
| T1 | 5.98 (2.26) | 7.18 (1.83) | 7.20 (1.67) |
| T2 | 6.20 (1.98) | 6.78 (1.73) | 7.69 (1.52) |
| T1-T0 | −0.41 (1.69) | 0.41 (2.29) | 0.61 (1.60) |
| T2-T0 | −0.30 (1.89) | −0.21 (2.15) | 0.92 (1.64) |
BDI-II, Beck II Self-Applied Depression Inventory; IPAQ-SF, Physical Activity Questionnaire-Short Form; PSQI, Pittsburgh Sleep Quality Index; MEDAS, Mediterranean Diet Adherence Screener; TAU, Treatment as Usual; LMP, Lifestyle Modification Programme; ICTs, Information and Communication Technologies; T0, Baseline assessment; T1, Post-intervention assessment; T2, Six-month follow-up.